Hua Zhong

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2026
Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis.

|May 07, 2026
GLUT6-facilitated noncanonical glucose metabolic rewiring enables resistance to targeted cancer therapy.

|Jun 28, 2023
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study.

Rong Qiao, Siyao Sang, Jiajun Teng

|Jan 28, 2021
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.

Runbo Zhong, Yunbin Zhang, Dongfang Chen

Pageof 1

Frequent Collaborators

3 joint publications

Baohui Han

1 joint publications

Siyao Sang

1 joint publications

Hui Li

1 joint publications

Jun Lu